MainScienceBiologyBiochemistry and Molecular Biology › Regulus Therapeutics

Regulus Therapeutics

Edit Page
Report
Scan day: 04 March 2014 UTC
7
Virus safety - good
Description: Biopharmaceutical company focused on development of microRNA therapeutics. Recently formed as a joint venture between Isis and Alnylam.
Regulus Therapeutics – A Leading microRNA Therapeutics Company | Regulus Therapeutics – a leading company developing microRNA therapeutics. Medicines that target the pathways of human disease.
Size: 212 chars

Contact Information

Email:
Phone&Fax:
Address:
Extended:

WEBSITE Info

Page title:Regulus Therapeutics – A Leading microRNA Therapeutics Company | Regulus Therapeutics – a leading company developing microRNA therapeutics. Medicines that target the pathways of human disease.
Keywords:microrna therapeutics, business development, media, Regulus Therapeutics information,microRNA,regulus,regulus san diego,micro rna,microRNA california
Description:Regulus Therapeutics - a leading company developing microRNA therapeutics. Medicines that target the pathways of human disease.
IP-address:67.222.32.150

WHOIS Info

NS
Name Server: NS51.DOMAINCONTROL.COM
Name Server: NS52.DOMAINCONTROL.COM
WHOIS
Status: clientDeleteProhibited
Status: clientRenewProhibited
Status: clientTransferProhibited
Status: clientUpdateProhibited
Date
Creation Date: 03-jan-2007
Expiration Date: 03-jan-2017